N4 Pharma
(LSE) N4P
N4 Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$12.93K
Net Income (TTM)
$2.18M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
N4P News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout N4 Pharma
Industry
Pharmaceuticals
Sector
Health CareCEO
Nigel James Theobald
Website
www.n4pharma.comHeadquarters
London, EC3V 0HR, GB
N4P Financials
Key Financial Metrics (TTM)
Gross Margin
48%
Operating Margin
-161%
Net Income Margin
-156%
Return on Equity
-91%
Return on Capital
-65%
Return on Assets
-60%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$7.28K
Operating Income
$1.22M
EBITDA
$1.22M
Operating Cash Flow
$971.50K
Capital Expenditure
$0.00
Free Cash Flow
$971.50K
Cash & ST Invst.
$625.97K
Total Debt
$0.00
N4 Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.69K
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
5
N/A
Net Income
$498.55K
+22.8%
EBITDA
$470.22K
+27.2%
Quarterly Fundamentals
Net Cash
$1.73M
+33.9%
Accounts Receivable
$118.11K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-59.74%
N/A
Return on Invested Capital
-64.51%
N/A
Free Cash Flow
$444.37K
+28.9%
Operating Cash Flow
$444.37K
+28.9%